Thus, SETDB2 expression and function detected in our study were similar to those of SETDB1 and SUV39H1 in cancers [5, 6], suggesting that SETDB2 may have oncogenic functions and overexpression of SETDB2 play roles in gastric cancer progression. The gene discussed is SUV39H1; the disease is gastric cancer.